-
Product Insights
Vestibular Schwannoma (Acoustic Neuroma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Vestibular Schwannoma (Acoustic Neuroma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Vestibular Schwannoma (Acoustic Neuroma) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Vestibular Schwannoma (Acoustic Neuroma), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history...
-
Product Insights
Neuroendocrine Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Neuroendocrine Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Neuroendocrine Carcinoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Neuroendocrine Carcinoma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
Primitive Neuroectodermal Tumor (PNET) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Primitive Neuroectodermal Tumor (PNET) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Primitive Neuroectodermal Tumor (PNET) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Primitive Neuroectodermal Tumor (PNET), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history...
-
Sector Analysis
T-Cell Lymphomas: Epidemiology Forecast to 2030
In the 8MM, the diagnosed incident cases of TCL are expected to increase from 27,263 cases in 2020 growing at an Annual Growth Rate (AGR) of more than 2% during 2021-2030. There is an increase forecasted in the five-year diagnosed prevalent cases of TCL from 90,275 cases in 2020 at an AGR of more than 2.5%. In 2020, for the 8MM combined, adults ages 60-69 years contributed the highest proportion of the diagnosed incident cases of TCL with more than...
-
Sector Analysis
Cervical Cancer Epidemiology Analysis and Forecast, 2020-2030
There were 109,891 cases of diagnosed incident cases of cervical cancer in the 8MM in 2020. The number of diagnosed incident cases is expected to increase further at an annual growth rate (AGR) of more than 1% during the forecast period. In 2030, urban China is expected to have the highest number of diagnosed incident cases of cervical cancer. The report cervical cancer epidemiology report provides an overview of the risk factors, comorbidities, and global and historical trends for cervical...
-
Product Insights
Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Melanomas usually occur on the skin but can arise in other locations where neural crest cells migrate, such as in the gastrointestinal tract or brain. It is more common in women than in men. The Melanoma pipeline market research report provides comprehensive information on the therapeutics under development for Melanoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the...
-
Product Insights
Small-Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Small cell lung cancer (SCLC) is the most aggressive form of lung cancer. These tumors often spread rapidly (metastasize) to other parts of the body, including the brain, liver, and bone. The Small-Cell Lung Cancer market research report provides comprehensive information on the therapeutics under development for SCLC, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its...
-
Product Insights
Gastrointestinal Stromal Tumor (GIST) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Gastrointestinal stromal tumors (GIST) belong to a group of cancers called soft tissue sarcoma. GISTs can be benign or malignant tumors. Its treatment involves the use of surgery, radiation therapy, targeted therapy, and chemotherapy. The Gastrointestinal Stromal Tumor pipeline market research report provides comprehensive information on the therapeutics under development for GIST, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action...
-
Product Insights
Myelodysplastic Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Myelodysplastic syndrome (MDS) is a condition that affects the bone marrow and the blood cells it produces. The condition rarely causes signs or symptoms in the early stages of the disease. The symptoms include fatigue, shortness of breath, unusual paleness (pallor) due to anemia, easy or unusual bruising or bleeding, and frequent infections. The Myelodysplastic Syndrome pipeline market research report provides comprehensive information on the therapeutics under development for Myelodysplastic Syndrome (Oncology), complete with analysis by stage of development, drug...
-
Product Insights
Bladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Bladder cancer occurs in tissues of the urinary bladder whose symptoms include blood or blood clots in the urine, frequent urination, lower back pain on one side of the body, and burning during urination. Risk factors for bladder cancer include smoking, exposure to substances such as rubber, certain dyes and textiles, paint, and hairdressing supplies, diet rich in fried meats and fat, old age, sex and color, and certain parasitic infections. The Bladder Cancer pipeline market research report provides comprehensive...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.